The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: To what extent should the results be generalizable? - 28/08/11
Doi : 10.1067/mhj.2003.180
Abstract |
The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study investigated the use of clopidogrel in the treatment of acute coronary syndromes. Clopidogrel treatment led to an impressive 20% relative risk reduction in the composite outcome measure of vascular death, myocardial infarction, and stroke. Increased bleeding and greater requirements for blood transfusions were seen with clopidogrel. The addition of clopidogrel to aspirin represents a major advance in the treatment of acute coronary syndromes. (Am Heart J 2003;145:595-601.)
Le texte complet de cet article est disponible en PDF.© 2003
Mosby, Inc. Tous droits réservés.
Vol 145 - N° 4
P. 595-601 - avril 2003 Retour au numéro
Article précédent
- Anticoagulation in acute cardiac care in patients with chronic kidney disease
- Donal Reddan, Lynda A. Szczech, Susan O'Shea, Robert M. Califf
- Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study
- Elizabeth R. Hauser, Vincent Mooser, David C. Crossman, Jonathan L. Haines, Christopher H. Jones, Bernhard R. Winkelmann, Silke Schmidt, William K. Scott, Allen D. Roses, Margaret A. Pericak-Vance, Christopher B. Granger, William E. Kraus
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?